News Focus
News Focus
icon url

arvitar

08/27/19 1:05 PM

#141534 RE: loanranger #141533

On a related point that I've brought up before: what Diwan can or can't produce in his Theracour lab is s big red herring. These rumors by "inside sources" are a part of it.

It's a distraction from the question: why didn't NNVC pay a professional contract CMC chemistry lab, that typically has a few centuries of specialized process design and scale-up chemistry experience distributed among its staff, to design and scale up the process for them?

It's completely predictable that Diwan, who has zero experience in such matters, wouldn't be able to lead a team over 14 years to accomplish what a competent group of chemists who specialize in solving these exact problems could do in few weeks.

The answer, in my opinion, is this has always been strong evidence that Diwan's only interest was having an excuse for NNVC to pay Theracour as much of that $92M as possible in salaries and R&D costs.
icon url

Nanotoday

08/27/19 1:40 PM

#141536 RE: loanranger #141533

What is not clear about: "Kilogram production has been done by combining multiple smaller batches"?

You say yourself that this isn't something you'd hear at check out at walmart, so what more elaboration do you expect knowing as you say that you don't expect me to name my source(s)?

Believe what you want. I make it all up. And remember this absurd statement:

...hard to predict that they would be so slow to get into trials. There is no way it should've taken this long to get an IND with the way they were talking so many years ago.



There were so many obvious red flags and completely FALSE statements made by the company, that anyone who uses their current statements as "proof" of something is clearly delusional.

I wonder what Seymour is doing these days?

Bwahahahahahahahahahahaha!